Hamburg – The synlab Group has acquired Laboratoire Dr. Collard of Belgium, which operates a total of 41 blood testing centres in Belgium and Luxembourg. synlab is Europe’s leading laboratory services company for human, veterinary and environmental analysis. In 2012, it generated sales of around EUR 625 million, according to provisional figures. The purchase price was not disclosed.
A cross-border team from CMS DeBacker and CMS Hasche Sigle advised the Augsburg-based group on all aspects of the acquisition.
The lab service provider is a portfolio company of global private equity firm BC Partners. The synlab Group was formed at the end of 2009 through the merger of three lab chains in Germany, Austria and Italy, with CMS Hasche Sigle partner Dr Udo Simmat advising in the lead role. Since then it has grown organically and through further acquisitions.
The acquisition in Belgium is part of synlab's ongoing expansion strategy. It is now represented at 300 locations in a total of 18 European countries, as well as Turkey, Saudi Arabia and Dubai. The group has some 6,800 employees and carries out around 1 million analyses each day.
CMS Hasche Sigle
Dr Jacob Siebert, M&A, Private Equity, Lead Partner Germany
Dr Christoph Lächler, Corporate/M&A
CMS DeBacker (Belgium)
Arnaud Van Oekel, Corporate/M&A, Lead Partner Belgium
David Prync, Corporate/M&A